Creative Biolabs-Immuno-oncology

Anti-LAG3 (clone Ab9Q) SynExpress E1-Cy2-I17-P Modified CD8+ T cells (CAT#: ITS-1224-CR1989)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target LAG3 (clone Ab9Q). We employs the pCDNA (EF1α-Cy2-IL-17-PstI) vector components and the SynExpress system of the Single base pair Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Humanized
Target
LAG3
Clone
Ab9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy2
Promoter
EF1α
Effector Gene
IL-17
Insertion Sites
PstI
Gene Modification
Knockout
Modification Domain
Single base pair
Carrier Type
pCDNA
Transformation Accuracy
0.91
Cell Culture
3D Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.